71 related articles for article (PubMed ID: 3455669)
21. Varicella vaccination--a critical review of the evidence.
Skull SA; Wang EE
Arch Dis Child; 2001 Aug; 85(2):83-90. PubMed ID: 11466178
[No Abstract] [Full Text] [Related]
22. Current pharmacological approaches to the therapy of varicella zoster virus infections: a guide to treatment.
Snoeck R; Andrei G; De Clercq E
Drugs; 1999 Feb; 57(2):187-206. PubMed ID: 10188760
[TBL] [Abstract][Full Text] [Related]
23. Can herpes zoster be prevented?
Levin MJ
Eur J Clin Microbiol Infect Dis; 1996 Jan; 15(1):1-3. PubMed ID: 8641298
[No Abstract] [Full Text] [Related]
24. Varicella-zoster virus as a live vector for the expression of foreign genes.
Lowe RS; Keller PM; Keech BJ; Davison AJ; Whang Y; Morgan AJ; Kieff E; Ellis RW
Proc Natl Acad Sci U S A; 1987 Jun; 84(11):3896-900. PubMed ID: 3035557
[TBL] [Abstract][Full Text] [Related]
25. The epidemiology of varicella-zoster virus infections: the influence of varicella on the prevalence of herpes zoster.
Garnett GP; Grenfell BT
Epidemiol Infect; 1992 Jun; 108(3):513-28. PubMed ID: 1318219
[TBL] [Abstract][Full Text] [Related]
26. The incidence of zoster after immunization with live attenuated varicella vaccine. A study in children with leukemia. Varicella Vaccine Collaborative Study Group.
Hardy I; Gershon AA; Steinberg SP; LaRussa P
N Engl J Med; 1991 Nov; 325(22):1545-50. PubMed ID: 1658650
[TBL] [Abstract][Full Text] [Related]
27. Live attenuated varicella vaccine use in immunocompromised children and adults.
Gershon AA; Steinberg SP; Gelb L
Pediatrics; 1986 Oct; 78(4 Pt 2):757-62. PubMed ID: 3020495
[TBL] [Abstract][Full Text] [Related]
28. The risk of zoster after varicella vaccination in children with leukemia.
Lawrence R; Gershon AA; Holzman R; Steinberg SP
N Engl J Med; 1988 Mar; 318(9):543-8. PubMed ID: 2828948
[TBL] [Abstract][Full Text] [Related]
29. Varicella-like illness caused by live varicella vaccine in children with acute lymphocytic leukemia.
Brunell PA; Geiser CF; Novelli V; Lipton S; Narkewicz S
Pediatrics; 1987 Jun; 79(6):922-7. PubMed ID: 3035478
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of varicella vaccine in childhood leukemia. Observation over 6 years.
Oka T; Iseki K; Oka R; Sakuma S; Yoshioka H; Takahashi M
Biken J; 1984 Sep; 27(2-3):103-9. PubMed ID: 6100045
[TBL] [Abstract][Full Text] [Related]
31. Risk of herpes zoster in children with leukemia: varicella vaccine compared with history of chickenpox.
Brunell PA; Taylor-Wiedeman J; Geiser CF; Frierson L; Lydick E
Pediatrics; 1986 Jan; 77(1):53-6. PubMed ID: 3455669
[TBL] [Abstract][Full Text] [Related]
32. Varicella prevention in the United States: a review of successes and challenges.
Marin M; Meissner HC; Seward JF
Pediatrics; 2008 Sep; 122(3):e744-51. PubMed ID: 18762511
[TBL] [Abstract][Full Text] [Related]
33. Modified chickenpox in children immunized with the Oka/Merck varicella vaccine.
Watson BM; Piercy SA; Plotkin SA; Starr SE
Pediatrics; 1993 Jan; 91(1):17-22. PubMed ID: 8416499
[TBL] [Abstract][Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
